NCT05327530: An ongoing trial by EMD Serono Research & Development Institute, Inc.
This trial is ongoing. It must report results 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05327530 |
|---|---|
| Title | A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 17, 2022 |
| Completion date | June 20, 2025 |
| Required reporting date | June 20, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |